BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22375924)

  • 1. The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.
    Rosin G; Hannelius U; Lindström L; Hall P; Bergh J; Hartman J; Kere J
    BMC Cancer; 2012 Feb; 12():79. PubMed ID: 22375924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for DYX1C1, a chaperone protein for both Hsp70 and Hsp90, in breast cancer.
    Chen Y; Zhao M; Wang S; Chen J; Wang Y; Cao Q; Zhou W; Liu J; Xu Z; Tong G; Li J
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1265-76. PubMed ID: 19277710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
    Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
    J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular networks of DYX1C1 gene show connection to neuronal migration genes and cytoskeletal proteins.
    Tammimies K; Vitezic M; Matsson H; Le Guyader S; Bürglin TR; Ohman T; Strömblad S; Daub CO; Nyman TA; Kere J; Tapia-Páez I
    Biol Psychiatry; 2013 Mar; 73(6):583-90. PubMed ID: 23036959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs3743205 SNP is important for the regulation of the dyslexia candidate gene DYX1C1 by estrogen receptor β and DNA methylation.
    Tammimies K; Tapia-Páez I; Rüegg J; Rosin G; Kere J; Gustafsson JÅ; Nalvarte I
    Mol Endocrinol; 2012 Apr; 26(4):619-29. PubMed ID: 22383464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction of DYX1C1 with estrogen receptors suggests involvement of hormonal pathways in dyslexia.
    Massinen S; Tammimies K; Tapia-Páez I; Matsson H; Hokkanen ME; Söderberg O; Landegren U; Castrén E; Gustafsson JA; Treuter E; Kere J
    Hum Mol Genet; 2009 Aug; 18(15):2802-12. PubMed ID: 19423554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
    Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
    Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer.
    BenAyed-Guerfali D; Dabbèche-Bouricha E; Ayadi W; Trifa F; Charfi S; Khabir A; Sellami-Boudawara T; Mokdad-Gargouri R
    Mol Biol Rep; 2019 Jun; 46(3):3247-3255. PubMed ID: 30941644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
    Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
    Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
    Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
    Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
    Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
    Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA; Clark GM; Mertz JE
    Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
    Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.
    Guo J; Gong G; Zhang B
    Tumour Biol; 2017 Jul; 39(7):1010428317713392. PubMed ID: 28671019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
    Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
    BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia.
    Tapia-Páez I; Tammimies K; Massinen S; Roy AL; Kere J
    FASEB J; 2008 Aug; 22(8):3001-9. PubMed ID: 18445785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.